chrisvoncsefalvay/vaers-outcomes huggingface dataset:
incomplete/partial dose Narrative:  Employee reports - needle I felt wetness on my arm, when I looked at the injection site, I saw a moderate amount of fluid under the dressing, when I brought up my concerns to the nurse she replied "I'm sure some made it in." When I returned to work I shared with my colleagues what happened and when assessing my injection site they confirmed there was a moderate amount of fluid under the dressing. The day after I received my first vaccine, my R arm, the arm in which I received my injection was very sore, the soreness radiated to the R side of my neck and I felt fatigued. Today, the day after receiving my second vaccine, have no arm soreness or any other post vaccine symptoms. Because of this, I believe I did not receive my second vaccine. 1/21 - received guidance from Pfizer. They make no recommendation about repeating a vaccine but sent guidance from the CDC regarding re-vaccination after a suspected partial dose was given. Recommendation is to use clinical judgement and with other vaccines CDC recommends re-vaccination as soon as possible. Will offer another 2nd vaccine to this employee.
Feet and legs swell and have pain, itch and subcutaneous hemorrhage. Heart rate increases.   Heart has cardiopalmus and sometime feel stopping . The skin color of feet and leg becomes brown.
About 2 days after the injection, my heart started beating very hard. It was not a rapid beat but noticeably hard. Saturday and Sunday I stayed prone which seemed to feel better.  On Monday, it seemed better and I had an EKG at my cardiologist?s office which came back fine. No trouble since then. Now I?ve just had my second shot.
Information has been received from a nurse practitioner concerning a 16 year old female who on an unspecified date was vaccinated intramuscularly with the first dose of Gardasil. Concomitant therapy included a tetanus toxoid shot. Immediately with vaccination, the patient developed injection site stinging and the patient passed out for a few seconds. The patient sought unspecified medical attention. The nurse practitioner reported that the patient was fine after a few seconds and was able to drive home. Thee was no lot number provided. Additional information has been requested.
Patient received 2nd dose of updated covid booster of Moderna Bivalent vaccine. Patient is 49 years old, and works with immunocompromised and is not eligible or fall under: "People aged 65 years and older may get a 2nd dose of updated Pfizer-BioNTech or Moderna COVID-19 vaccine." per CDC guidelines.
Patient presented to hospital for Covid, treated with steroids, oxygen and remdesivir. Patient discharged home.
PATIENT COMPLAINING ARM IS VERY SORE AND SHE CAN'T EVEN LIFT HER HAND.
20 hrs p/Pneumonococcal vax, rt arm swelled up & was very sore; low grade fever 99F (pt states body temp has always been sub-abnormal; w/chills; arthralgia; for which lasted 60 hrs; @ this date 15NOV91; rt arm is still sl swollen & bruised;
chills in extremities, dizziness, headache, rash/swollen skin about 3 inches surrounding injection site
01/15/2022 my family came and said they were taking me to the ER because I wasn't finishing my sentences and I didn't know what it was or anything. They took me to the ER and from there they did a CT scan and at the same time had a TIA stroke and couldn't use contrast, but they tested me for Covid as well and it was positive. They put me on the covid floor and all the normal stuff happened like low blood oxygen and so they gave me antibiotics and steroids and then weaned me off of the oxygen and I did good and they discharged me on 01/19/2022. I do know that since I've been out of the hospital I've felt better than I've felt in months. I'm pain free and sleeping. I have been left with a dry cough but that's it.
Information has been received from a physician concerning an adult male who developed shingles after his wife was vaccinated with a dose of Zostavax in approximately November 2006. Three days after his wife was vaccinated the patient developed what appeared to be a mild case of shingles. Unspecified medical attention was sought. As of 13 Dec 2006 the lesions were resolving and he was almost fully recovered. There was no product quality complaint involved. Additional information has been requested.
shot given 3-5-21 3-7-21 at 2:00 am was woken up by bad muscle and joint pains. But I was freezing. I had the chills very badly  I sleep with an electric blanket, but I had not had chills in years. I was very sore and cold, but did not do anything until 4:00am. I went and got an expired prescription of oxycontin. I took 2 and went back to bed. I woke up at 6 and was fine. So it lasted maybe 4 hours.
patient was being observed for 30 mins after injection and 20 mins within the observation patient started to develop symptoms of:  shortness of breath, left leg numbness and chest pressure. Blood pressure was at 207/97 and pulse was 113, no meds were given to patient. 911 was call and patient was transported to hospital at 12:50pm
Hep B vaccine has caused my face to droop, facial parasthesia, migraine, nerve pain in my left leg, muscle spasms, twitching. It has had me have to have an MRI of my brain, numerous doctors visits, loss of grades in school due to not being able to concentrate. Neuro appointment has classified my nervous system issues from adverse reaction to the hep b vaccine.
Itchy rash on torso (front and back) appeared about 4 hours later. Still have it- 5 days later.
Extremely fatigued; sore; Severe arm pain; Did not want to get out of bed; This non-serious case was reported by a other health professional via sales rep and described the occurrence of fatigue in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix .5 ml. On an unknown date, 1 day after receiving Shingrix, the patient experienced fatigue (Verbatim: Extremely fatigued), pain (Verbatim: sore), pain in arm (Verbatim: Severe arm pain) and bedridden (Verbatim: Did not want to get out of bed). The outcome of the fatigue, pain and bedridden were resolved (duration 2 days) and the outcome of the pain in arm was resolved (duration 36 hrs).   It was unknown if the reporter considered the fatigue, pain, pain in arm and bedridden to be related to Shingrix.     It was unknown if the company considered the fatigue, pain, pain in arm and bedridden to be related to Shingrix.   Additional Information: Receipt Date: 20-AUG-2023 The patient self reported severe arm pain for 24 to 36 hours following Shingrix vaccine. The patient stated that she was extremely fatigues and sore and did not want to get out of bed the day following her Shingrix vaccine. The patient was completely fine 2 days later.
The day before I had stomach pains not too severe but off and on during the day. Then I woke the next morning at 4:30am with severe pain. Eventually, I decided I needed to go to the emergency room. I was given a blood test, urinalyses and a CAT scan. The CAT scan is was showed that I had diverticulitis.
Swollen Arm ( August 20th- August 27th) Extreme Tachycardia both SVT and VT  (September 3rd - November 30th)  Intense chest pain, Arm , under arm and Shoulder Pain (September 2nd- present)  Shortness of Breath ( September 3rd - present )  Jaw pain ( November 1st 1 present)
Experiencing extreme and sudden pain in my lower back spine on the waist area trying to stand up from a crouching position after I tied my shoes. This pain does not go away and is hurting whenever I exhibit any force to my waist. This means I cannot twist or bend forward or backward because it would exhibit force on my spine. I cannot easily get out of bed or shift from one position to another.
died as a result of the COVID-19 vaccine shot; This is a spontaneous report from a contactable consumer reporting same event under the same suspect product for twenty patients. This is one of twenty reports.  A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported.  The reporter personally knows of 20 people who have died as a result of the COVID-19 vaccine shot. The patient died on an unspecified date. It was not reported if an autopsy was performed.  The lot number for BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101393431 same reporter, product/event; different patient; Reported Cause(s) of Death: died as a result of the COVID-19 vaccine shot
This spontaneous report was received from a male patient of unknown age. On an unknown date the patient was vaccinated with GARDASIL (dose, route, lot # and indication not reported). On an unknown date the patient lost his hair after having had GARDASIL. The outcome of lost his hair was unknown. The patient spoke with the FDA for medical attention. Additional information has been requested.
L arm near site injection ached and felt sore when using arm, pain and stiffness also noticed in the neck area on left side. Shoulder pain about 6 inch area near top of shoulder 4-5 days, neck is still stiff and sore 3-4 days after injection of course #2. Course #1 site injection ached and was sore also. No treatment, soreness slowly subsided.
Chill like sensations; Aches; Dyspnea on Exertion; General Malaise; Fever; Persistent headache that is not relieved with pain killers; other vaccine same date vaccine date 22Dec2020, dose number 1; other vaccine same date vaccine date 22Dec2020, dose number 1; This is a spontaneous report from a contactable consumer. A 40-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899, expiry date not reported), intramuscular in the right arm on 22Dec2020 07:30 at single dose for COVID-19 immunisation. Medical history was none. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was vaccinated at a hospital. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has been tested for COVID-19. The patient had no allergies to medications, food, or other products. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL XR), amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL IR), vitamin d3, calcium ascorbate (VITAMIN C), vitamin b complex, magnesium, cynara cardunculus extract (ARTICHOKE EXTRACT), and vaccinium macrocarpon (CRANBERRY EXTRACT). On 23Dec2020 07:00, the patient experienced chill like sensations, aches, dyspnea on exertion, general malaise, fever, persistent headache that is not relieved with pain killers. It was also reported that other vaccine with same date vaccine date on 22Dec2020, dose number 1. The patient underwent lab tests and procedures which included salivary sample (SARS-cov-2 test): negative on 01Dec2020  . No treatment was received for the adverse events. Clinical outcome of the events was recovered on an unspecified date.
Lymph sites in pain; Diarrhea; Headache; Heart racing; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the arm left on 29Apr2021 at 10:15 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history included postural orthostatic tachycardia syndrome (POTS), autonomic malfunction, vasovagal syncope, sulfonamide allergy, calling family allergy, latex allergy and adhesive allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included esomeprazole sodium (NEXIUM), topiramate (MANUFACTURER UNKNOWN), pyridostigmine (MANUFACTURER UNKNOWN), levothyroxine sodium (TIROSINT) and bupropion hydrochloride (WELLBEN); all for an unknown indication from an unknown date and unknown if ongoing. The patient previously received paracetamol; oxycodone hydrochloride (PERCOCET) on an unknown date and experienced drug allergy. On 29Apr2021 at 11:00 (day 1), the patient experienced diarrhea, headache, heart racing. On an unknown date in Apr2021 (Day 2-3), the patient experienced lymph sites in pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events diarrhea, headache, heart racing and lymph sites in pain was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.
a dose of PROQUAD was administered with VARIVAX; This spontaneous report was received from a pharmacy technician referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history, drug reactions/allergies and concomitant therapies were not reported.  On 04-APR-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) 1 dose, lot #U024221, expiration date 04-AUG-2023 (strength and route were not provided), with measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant Human albumin (rHA) (PROQUAD) 1 dose, lot #U028179, expiration date 08-MAR-2023 (strength and route were not provided) for prophylaxis (overdose). The pharmacy technician reported the information was shared with her by a nurse at one of their facility's clinic. It was unknown if any product confusion occurred, that may have contributed to the error.   This is one of eight reports received from the same reporter.
The vaccine Save he's life after contacting covid; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (The vaccine Save he's life after contacting covid) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014F21A) for COVID-19 vaccination.     No Medical History information was reported.    In September 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (The vaccine Save he's life after contacting covid). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (The vaccine Save he's life after contacting covid) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Reporter stated that caller called to say thank you about having the moderna vaccine last sept 2021 with Lot:014F21A. The vaccine saved he's life after contacting covid. No treatment medications were reported.
pt recvd vax; 2 hrs later exp v, n, warmth & dizziness; resolved p/ 48 hrs;
patient received .25 ml of booster but thought he received a full dose for a 3rd dose. Dr told him to come get a 3rd dose but had booster. Patient informed that it was .25 not .5 and he was told he could receive the other .25 ml but did not want restuck. He said he may return in the next 2 weeks to receive the other .25 and was told after that he would need to wait for 6 months if a booster was then wanted. No adverse effects to patient just not the full dose given for a 3rd dose for immunocompromised individual.
1st Pregnancy - estimated due date of 06/29/2021 Vaccine side effects: . Sore at injection site - 12 hours after receiving vaccine - lasted for 48 hours. Fatigue - 2 hours after receiving vaccine - lasted for 12 hours. Headache - 12 hours after receiving vaccine - lasted for 12 hours. No medical treatment necessary.
One week following injection, I experienced a rash on my upper left arm around the injection site.  This rash began small, and is now an oval about 4" by 2."  It is itchy and red.  This appears to be the only reaction, so far.
Soreness at the injection site; chills; very tired; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 26Apr2021 (Lot number: EW0165) at the age of 33 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "known_allergies:Scented soaps/perfumes" (unspecified if ongoing); "Irritable bowel syndrome" (unspecified if ongoing); "Migraine" (unspecified if ongoing); "Anxiety/depression" (unspecified if ongoing); "depression" (unspecified if ongoing). Concomitant medication(s) included: VIIBRYD; WELLBUTRIN; BUSPAR; TERAZOSIN; VITAMIN D. Vaccination history included: Bnt162b2 (Dose 1, Single; Manufacturer unknown;, Lot Number: ER8733; Anatomical site: Left Arm), administration date: 05Apr2021, when the patient was 33 years old, for COVID-19 immunization, reaction(s): "soreness at the injection site". The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "recovered" (2021), described as "Soreness at the injection site"; CHILLS (non-serious) with onset 2021, outcome "recovered" (2021), described as "chills"; FATIGUE (non-serious) with onset 2021, outcome "recovered" (2021), described as "very tired". Therapeutic measures were not taken as a result of vaccination site pain, chills, fatigue.  Additional information: Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  No follow-up attempts are possible. No further information is expected.
Fever ( temp 100.5 ), chills and body shaking Legs very week, barely walk and legs collapsed twice so went to bed  for most on day. Slight metal taste in mouth. Didn't want to eat. Shot on Sun., down for count on Mon.,felt better on Tues and Ok by Wed.
This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt very sick), SUSPECTED COVID-19 (Covid like symptoms), ILLNESS ("super sick''), PRODUCT DOSE OMISSION ISSUE (Consumer chose not to get the second dose of the Moderna vaccine) and FEELING ABNORMAL (I felt horrible") in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 (diagnosed) in November 2020. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced MALAISE (Felt very sick), SUSPECTED COVID-19 (Covid like symptoms), ILLNESS ("super sick''), PRODUCT DOSE OMISSION ISSUE (Consumer chose not to get the second dose of the Moderna vaccine), FEELING ABNORMAL (I felt horrible"), NAUSEA ("I was nauseous the next morning"), MYALGIA (her arm was pretty sore/achy), FATIGUE ("tired"), HEADACHE (headache) and VACCINATION SITE PAIN (Arm is sore at the site of injection). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Pain in arm, at a dose of 2 dosage form. On 08-Mar-2021, MALAISE (Felt very sick) and VACCINATION SITE PAIN (Arm is sore at the site of injection) had resolved, SUSPECTED COVID-19 (Covid like symptoms) outcome was unknown. At the time of the report, ILLNESS ("super sick''), PRODUCT DOSE OMISSION ISSUE (Consumer chose not to get the second dose of the Moderna vaccine), FEELING ABNORMAL (I felt horrible"), NAUSEA ("I was nauseous the next morning"), MYALGIA (her arm was pretty sore/achy), FATIGUE ("tired") and HEADACHE (headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter.  Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: Significant Follow-up appended, events added.
I was admitted to the E.R at Medical Center for Chest pain, come to find out that the chest pain was caused by Pericarditis due to the Moderna Booster Vaccine.
Had an allergic reaction to an unknown allergen. Have only ever had one allergic reaction as an infant to penicillin and have never had any other allergic reaction. Did not change or do anything different before this reaction. Primary care Dr. stated that maybe a new sensitivity had arisen and was somehow connected to vaccination, however not 100% sure. Blood work done and no new allergy found/identified. Spent a couple hours in the ED after initial reaction and went through various drugs before resolved (lasted about a month). Now completely resolved, have changed nothing and have not had reaction again.
First dose of Shingrix was administered in 2019 to a patient and no second dose has been administered yet; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included shingrix (1st dose received on 18th November 2019).   On an unknown date, the patient did not received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: First dose of Shingrix was administered in 2019 to a patient and no second dose has been administered yet). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 28-SEP-2023. Pharmacist called to report that a first dose of Shingrix was administered in 2019 to a patient and no second dose had been administered yet. The reporter consented to follow up. The follow up was agreed via email. Lot number was asked to reporter, but the information was not available. The reporter reported that till the time of reporting the patient had not received the 2nd dose of Shingrix vaccine, which lead to incomplete course of vaccination.
Monovalent doses administered after the BUD to patient; no adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patient) and NO ADVERSE EVENT (no adverse event) in an adolescent female patient who received mRNA-1273 (Spikevax) (batch no. 059H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 04-Mar-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patient) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patient) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown.   For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patient).    No concomitant medication information was provided. No treatment medications were provided
Patient accidentally received the vaccine for Moderna Pediatric instead of receiving the Moderna Bivalent dosing. No adverse reactions.